Literature DB >> 21128737

Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice.

Lifen Chen1, Xuefeng Zhang, Jing Chen-Roetling, Raymond F Regan.   

Abstract

OBJECT: Heme toxicity may contribute to the pathogenesis of intracerebral hemorrhage (ICH). The primary defense against extracellular heme is provided by hemopexin, a serum and neuronal glycoprotein that binds it with very high affinity and mitigates its prooxidant effect. In the present study, the authors tested the hypothesis that hemopexin knockout mice would sustain more injury after experimental ICH than their wild-type counterparts.
METHODS: Striatal ICH was induced by the stereotactic injection of bacterial collagenase or autologous blood. Three days later, striatal protein oxidation was assessed via carbonyl assay. Cell viability was quantified at 8-9 days by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Behavioral deficits were detected with high-resolution digital analysis of 6-hour home cage video recordings and standard testing.
RESULTS: Perihematomal protein oxidation was increased in wild-type collagenase-injected striata by approximately 2.1-fold, as compared with contralateral striata; protein carbonyls were increased 3-fold in knockout mice. Striatal cell viability was reduced by collagenase injection in wild-type mice to 52.9 ± 6.5% of that in the contralateral striata, and to 31.1 ± 3.7% of that in the contralateral striata in knockout mice; similar results were obtained after blood injection. Digital analysis of 6-hour video recordings demonstrated an activity deficit in both models that was significantly exacerbated at 8 days in knockout mice. Striatal heme content 9 days after blood injection was increased approximately 2.7-fold in knockouts as compared with wild-type mice.
CONCLUSIONS: These results suggest that hemopexin has a protective effect against hemorrhagic CNS injuries. Hemopexin deficiency, which is often associated with sickle cell disease, may worsen outcome after ICH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21128737      PMCID: PMC3061252          DOI: 10.3171/2010.10.JNS10861

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  44 in total

1.  Gauging recovery after hemorrhagic stroke in rats: implications for cytoprotection studies.

Authors:  Crystal L MacLellan; Angela M Auriat; Steven C McGie; Reginia H Y Yan; Hang D Huynh; Maxine F De Butte; Frederick Colbourne
Journal:  J Cereb Blood Flow Metab       Date:  2005-12-14       Impact factor: 6.200

Review 2.  Mechanisms of brain injury after intracerebral haemorrhage.

Authors:  Guohua Xi; Richard F Keep; Julian T Hoff
Journal:  Lancet Neurol       Date:  2006-01       Impact factor: 44.182

3.  The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington's and prion diseases.

Authors:  Andrew D Steele; Walker S Jackson; Oliver D King; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-29       Impact factor: 11.205

4.  Time course of increased heme oxygenase activity and expression after experimental intracerebral hemorrhage: correlation with oxidative injury.

Authors:  Mai Chen; Raymond F Regan
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

Review 5.  Clinical significance of acute phase reaction in stroke patients.

Authors:  Tomasz Dziedzic
Journal:  Front Biosci       Date:  2008-01-01

6.  Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons.

Authors:  Da-Zhi Liu; Xi-Yuan Cheng; Bradley P Ander; Huichun Xu; Ryan R Davis; Jeffrey P Gregg; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2008-02-09       Impact factor: 5.996

7.  Heme-hemopexin complex attenuates neuronal cell death and stroke damage.

Authors:  Rung-chi Li; Sofiyan Saleem; Gehua Zhen; Wangsen Cao; Hean Zhuang; Jongseok Lee; Ann Smith; Fiorella Altruda; Emanuela Tolosano; Sylvain Doré
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-11       Impact factor: 6.200

8.  Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury.

Authors:  Masatoshi Ohnishi; Hiroshi Katsuki; Shinji Fujimoto; Mikako Takagi; Toshiaki Kume; Akinori Akaike
Journal:  Exp Neurol       Date:  2007-04-14       Impact factor: 5.330

9.  Attenuation of oxidative injury after induction of experimental intracerebral hemorrhage in heme oxygenase-2 knockout mice.

Authors:  Yan Qu; Jing Chen-Roetling; Luna Benvenisti-Zarom; Raymond F Regan
Journal:  J Neurosurg       Date:  2007-03       Impact factor: 5.115

10.  Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload.

Authors:  Francesca Vinchi; Stefania Gastaldi; Lorenzo Silengo; Fiorella Altruda; Emanuela Tolosano
Journal:  Am J Pathol       Date:  2008-06-13       Impact factor: 4.307

View more
  43 in total

1.  Systemic hemin therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage.

Authors:  Xiangping Lu; Jing Chen-Roetling; Raymond F Regan
Journal:  Neurobiol Dis       Date:  2014-06-18       Impact factor: 5.996

2.  Genetic deletion of the prostaglandin E2 E prostanoid receptor subtype 3 improves anatomical and functional outcomes after intracerebral hemorrhage.

Authors:  Jenna L Leclerc; Andrew S Lampert; Matthew A Diller; Sylvain Doré
Journal:  Eur J Neurosci       Date:  2015-05       Impact factor: 3.386

3.  Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment.

Authors:  Hussein Abou-Abbass; Hisham Bahmad; Hadi Abou-El-Hassan; Rui Zhu; Shiyue Zhou; Xue Dong; Eva Hamade; Khalil Mallah; Abir Zebian; Naify Ramadan; Stefania Mondello; Jawad Fares; Youssef Comair; Samir Atweh; Hala Darwish; Kazem Zibara; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-03-29       Impact factor: 3.535

4.  Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?

Authors:  Vladimir V Bamm; George Harauz
Journal:  Cell Mol Life Sci       Date:  2014-02-07       Impact factor: 9.261

5.  Hemopexin decreases hemin accumulation and catabolism by neural cells.

Authors:  Jing Chen-Roetling; Wenpei Liu; Raymond F Regan
Journal:  Neurochem Int       Date:  2012-02-07       Impact factor: 3.921

6.  Hemoglobin metabolism by-products are associated with an inflammatory response in patients with hemorrhagic stroke.

Authors:  Cássia Righy; Ricardo Turon; Gabriel de Freitas; André Miguel Japiassú; Hugo Caire de Castro Faria Neto; Marcelo Bozza; Marcus F Oliveira; Fernando A Bozza
Journal:  Rev Bras Ter Intensiva       Date:  2018-03-15

Review 7.  A critical appraisal of experimental intracerebral hemorrhage research.

Authors:  Crystal L MacLellan; Rosalie Paquette; Frederick Colbourne
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-01       Impact factor: 6.200

8.  A rapid fluorescent method to quantify neuronal loss after experimental intracerebral hemorrhage.

Authors:  Jing Chen-Roetling; Xiangping Lu; Kathleen A Regan; Raymond F Regan
Journal:  J Neurosci Methods       Date:  2013-04-10       Impact factor: 2.390

9.  Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.

Authors:  Gregory M Vercellotti; Ping Zhang; Julia Nguyen; Fuad Abdulla; Chunsheng Chen; Phong Nguyen; Carlos Nowotny; Clifford J Steer; Ann Smith; John D Belcher
Journal:  Mol Med       Date:  2016-07-19       Impact factor: 6.354

10.  Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states.

Authors:  Peter Hahl; Taron Davis; Cecilia Washburn; Jack T Rogers; Ann Smith
Journal:  J Neurochem       Date:  2013-02-25       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.